Applications

1627 – Point-of-care testing for sexually transmitted infections provided by Aboriginal Medical Services or Aboriginal Community Controlled Heath Services in rural or remote areas

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation Closed
  • Pre-MSAC consultation Closed
  • Outcome Not supported

Application details

Reason for application

New MBS items.

Service or technology in this application

Rapid on-demand nucleic acid amplification test for use at point-of-care in clinics servicing remote communities enabling laboratory equivalent, on-the-spot diagnosis for Chlamydia trachomatis, Neisseria gonorrhoea, and/or Trichomonas vaginalis infection within 90 minutes, facilitating antibiotic treatment for patients and initiation of contact tracing.

Type: Investigative

Medical condition this application addresses

Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis are sexually transmitted bacterial infections, often asymptomatic, mostly affecting young people aged 15-29 years. Easily cured with antibiotics, untreated infection can cause pelvic inflammatory disease resulting in chronic abdominal pain, as well as increasing the risk of tubal infertility and ectopic pregnancy.

Consultation survey and deadlines

  • PASC consultation: Closed
  • MSAC consultation: Closed Friday 7 October 2022

Meetings to consider this application

  • PASC meeting: 12 to 13 August 2021
  • ESC meeting: 6 to 7 October 2022
  • MSAC meeting: 24 to 25 November 2022